Where conviction is rising: core U.S. beta and selective AI winners
Look at the biggest adds and the message is clear: incremental dollars went straight into diversified beta, with a modest side of AI infrastructure.
- SCHX (Schwab U.S. Large-Cap) was lifted by +18.7%, a roughly $799.1M add, cementing it as the single largest position at 5.53%. That is a statement that the U.S. large-cap index itself is the house view.
- IVV (S&P 500) was boosted +13.1%, adding about $570.3M; SPY also ticked higher. Running multiple S&P-like sleeves is more about liquidity and operational flexibility than a nuanced macro call.
- VO (Vanguard Mid-Cap) rose +5.5%, a ~$95.8M add, reinforcing a barbell within core U.S. – large and mid, but less emphasis on the riskiest small-cap tail.
- IXUS and IEFA together saw fresh money (IXUS up +19.4%, about $180.6M; IEFA up modestly). That’s an incremental nod to international developed diversification, but still via broad, low‑tracking‑error vehicles.
- On the single-stock side, NVIDIA and Meta were both notably topped up (NVDA +2.2%, ~$35.0M; META +5.9%, ~$34.6M). Those are not speculative entries; they’re adds to long-held, massively profitable winners the fund is content to let run.
Rising conviction, in short, sits with the indices and with a handful of scale AI and cloud platforms that already dominate the benchmarks.
Conviction
The big buys
The biggest dollar adds this quarter — where conviction is rising.
| Position | Change | Portfolio weight | Value |
|---|---|---|---|
| SCHXSCHWAB STRATEGIC TR | Added 18.7%+$799.1M | 5.5% | $5.07B |
| IVVISHARES TR | Added 13.1%+$570.3M | 5.4% | $4.93B |
| IXUSISHARES TR | Added 19.4%+$180.6M | 1.2% | $1.11B |
| VOVANGUARD INDEX FDS | Added 5.5%+$95.8M | 2.0% | $1.84B |
| NVDANVIDIA CORPORATION | Added 2.2%+$35.0M | 1.8% | $1.65B |
| METAMETA PLATFORMS INC | Added 5.9%+$34.6M | 0.7% | $622.6M |
| IEFAISHARES TR | Added 0.9%+$31.3M | 3.8% | $3.48B |
| SPYSTATE STR SPDR S&P 500 ETF T | Added 0.9%+$28.2M | 3.4% | $3.14B |
Dollar changes estimated at current prices (shares added × current price); top-50 current positions only.
What they’re selling: small caps, bonds, and a bit of froth at the edges
The funding leg of the quarter is just as telling: this is a clean-up of riskier or lower-conviction wrappers, not a repudiation of any sector.
- IWM (Russell 2000) was hammered, down -38.6% in shares and roughly $401.5M in value. That’s the sharpest expression of a step back from small-cap risk, especially the most volatile, rate-sensitive corners.
- AGG (core U.S. aggregate bond) was cut -7.2%, freeing about $303.9M even though the position still sits at 4.27%. With AGG showing a slight loss versus their average cost, they’re accepting modest pain to re-risk into equities.
- VEA and VNQ were both trimmed (VEA -9.7%, about -$79.7M; VNQ -8.9%, about -$47.3M), hinting at some skepticism around ex‑U.S. developed and listed real estate as efficient uses of risk right now.
- Micron’s -10.2% cut (roughly -$100.8M) stands out among single names: in an otherwise pro‑AI stance, they’re trimming a high‑beta memory name after enormous gains, while leaving NVIDIA and Broadcom on the field.
- Smaller reductions in QQQ, VTI, and various style/small-cap ETFs suggest a general consolidation: fewer overlapping beta sleeves, more size in the preferred ones.
Nothing here screams “sector call”; this looks like housekeeping — pulling back from thinly compensated volatility and simplifying the toolkit.
How exposure is shifting: same sectors, different wrappers
On the surface, sector weights barely moved: technology dipped from 20.78% to 20.52%, consumer from 6.46% to 6.37%, health care from 5.42% to 5.35%. The real story is that the Unclassified bucket — i.e., broad ETFs — inched higher to 62.91%, and those ETFs themselves are heavily tech- and growth-laden.
The trims line up tightly with the bar chart: tiny step-downs in energy (via XOM), industrials (CAT), and financials (JPM) are all marginal. The real de‑risking is factor-based: less small-cap (IWM, IJR, MDY), less REIT exposure (VNQ, SCHH partly offsetting), and a notch less rate sensitivity from AGG.
By contrast, they added to broad developed ex‑U.S. (IEFA, IXUS) and kept emerging markets (IEMG) roughly stable despite a minor trim. That hints at a view that non‑U.S. equities are useful diversifiers, but not worth a bold overweight.
Within tech, the weight stability masks a quality upgrade: slight reductions in Micron and AMD, incremental adds to NVIDIA, Broadcom, Meta, Microsoft, and Alphabet. The sector chart won’t show it, but the risk profile inside the technology sleeve is migrating toward cash‑rich, platform‑type compounders.
What this playbook implies for the next leg
Put together, this quarter reads like a portfolio architect who believes the next phase of returns will come from owning the major indices, not from clever tilts. The fund is rebuilding around scalable, benchmark-like exposures and letting mega-cap platforms deliver the growth inside those wrappers.
Pulling capital from small caps and aggregate bonds into SCHX, IVV, and VO says they see better risk/reward in equity beta than in duration or lower-quality U.S. cyclicals. The modest but real adds to international developed ETFs show they’re not betting on U.S. exceptionalism alone, yet they’re in no rush to make dramatic regional calls.
The tech stance is particularly telling: they are not chasing new AI narratives; they are reinforcing existing, high‑margin winners and trimming the most volatile semis. If markets stay supportive, this structure should participate robustly in upside with less blow‑up risk from concentrated single-stock bets.
Investors watching US Bancorp De’s book should expect more of the same: incremental rebalancing around a broad equity core, tweaks at the factor level, and only measured moves in individual names. The message this quarter is almost old-fashioned — size the beta right, and let compounding do the hard work.
Rotation
How the book's themes shifted
Portfolio weight by theme, this quarter versus last.
Frequently asked questions
What did US Bancorp De buy in 2026 Q2?+
In 2026 Q2, US Bancorp De added most aggressively to broad equity ETFs like SCHX, IVV, VO, IXUS, IEFA, and SPY, and also increased positions in NVIDIA, Meta Platforms, Broadcom, and several other mega-cap tech and health care names.
What is US Bancorp De's biggest holding as of 2026 Q2?+
The largest disclosed holding at 2026 Q2 quarter-end is SCHX (Schwab U.S. Large-Cap ETF) at 5.53% of the reported portfolio, followed closely by IVV (iShares S&P 500 ETF) at 5.38%.
How did US Bancorp De change its sector exposure in 2026 Q2?+
Headline sector weights moved only slightly, but the Unclassified bucket of broad ETFs rose to 62.91%, while technology, consumer, and health care each dipped by a few basis points. Under the hood, they reduced small-cap, REIT, and bond exposure and concentrated more in large-cap equity beta.
Did US Bancorp De increase or decrease small-cap exposure in 2026 Q2?+
US Bancorp De clearly reduced small-cap exposure, most notably cutting IWM by -38.6% and trimming other small- and mid-cap ETFs like IJR, MDY, VTI, and some style funds while adding to large-cap and mid-cap index products.
How is US Bancorp De positioned on technology and AI stocks?+
Technology remains a core exposure at about 20.5% of the book. The firm modestly increased NVIDIA, Meta Platforms, Microsoft, Alphabet, and Broadcom, while trimming Micron and AMD, suggesting a preference for established AI and cloud platforms over more volatile semiconductor plays.
What is US Bancorp De's recent performance track record?+
Over the three years to 2026 Q2, the reported portfolio delivered a weighted annualized return of 16.38% (57.62% cumulative), with 2026 Q2 itself up 11.71%.